Expression of tamoxifen-inducible cre-ERT2 is driven from the mouse Cdh3 promoter contained on BAC RP23-267K22. A truncated Cdh1 (~50%) is also incorporated on the transgenic BAC. The modified BAC vector was introduced to C57BL/6J embryos. This is founder line NIDA158. (J:239228)